Spinal Cord Stimulation vs DRG Stimulation: How to Choose
If you’ve been told you might be a candidate for neuromodulation but you’re not sure which type fits your specific pain, this page walks through the practical differences between traditional spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation. Both implant a small device that delivers electrical impulses to modify how pain signals travel; the key difference is where in the nervous system the stimulation is applied.
I’m Dr. Keith Schmidt, a triple board-certified pain medicine physician in Hoffman Estates, Illinois. I implant both technologies in my practice, and I’ll match the right one to your specific pain pattern.
Quick comparison
What spinal cord stimulation does
Traditional spinal cord stimulation places electrodes in the epidural space along the spinal cord. The stimulation modulates pain signals before they reach the brain. SCS is well-established for diffuse, multi-area neuropathic pain — failed back surgery syndrome with leg pain, broad lower-extremity neuropathy, and similar patterns.
What DRG stimulation does
Dorsal root ganglion stimulation places electrodes adjacent to specific dorsal root ganglia — the cell bodies of sensory nerves entering the spinal cord. DRG stimulation is exquisitely targeted to focal pain that follows a specific nerve distribution: foot pain, knee pain, groin pain, post-amputation phantom or stump pain, and complex regional pain syndrome of an extremity.
When to choose SCS
Spinal cord stimulation is generally the right choice when your pain is diffuse rather than focal. If your pain covers a broad area — most of the lower back and one or both legs, large areas of arm or shoulder, or wide regions affected by neuropathy — traditional SCS provides effective coverage.
SCS also has the longer track record. For failed back surgery syndrome with predominantly leg pain, painful diabetic peripheral neuropathy, and chronic intractable trunk pain, SCS is the established first-line neuromodulation option.
When to choose DRG stimulation
DRG stimulation excels when the pain is focal and follows a specific dermatome. The classic indications include:
Complex regional pain syndrome of a foot, knee, or hand. The targeted nature of DRG stimulation produces relief that traditional SCS often can’t match in these focal CRPS presentations.
Post-surgical pain in a specific area — knee, groin, hand, or foot — that hasn’t responded to conventional treatment.
Phantom limb pain or post-amputation stump pain. The DRG can be targeted to the specific nerve roots that supply the painful area.
Pain in areas where traditional SCS coverage is technically difficult — particularly the foot.
Key differences at a glance
Both procedures involve a 5-7 day trial before permanent implantation. Both are MRI-conditional with newer systems. Both are covered by major insurance plans including Medicare when conservative care has been documented.
The implantation procedure is similar, though DRG lead placement requires more precise targeting of specific dorsal root ganglia. Battery life and replacement schedules are comparable.
The key clinical difference is coverage pattern: SCS gives broad, diffuse pain modulation; DRG gives focal, dermatomal pain modulation. The choice between them is usually clear once we map exactly where your pain is and what specific nerve distribution it follows.
Frequently Asked Questions
Can I have both SCS and DRG stimulation?
In some cases, yes. Patients with both diffuse and focal pain components sometimes benefit from a combined approach. This is uncommon but technically possible with modern systems.
Which has the better trial success rate?
For appropriately selected patients, both technologies have high trial success rates. The key is matching the technology to the right pain pattern. DRG, when used for focal CRPS or specific dermatomal pain, often produces dramatic relief that traditional SCS doesn’t reach.
Is the recovery different?
Recovery is generally similar between SCS and DRG. Most patients return to normal activities within 4-6 weeks, with activity restrictions during the first week to allow incisions to heal.
Are the long-term outcomes different?
Long-term outcomes depend more on patient selection than on which technology is used. When the right device is matched to the right pain pattern, both produce durable relief in most patients. Inappropriate matching is the main reason a procedure underperforms.
Will my insurance cover both options?
Most major insurance plans including Medicare cover both SCS and DRG stimulation when conservative care has been documented. Coverage criteria are similar; the choice between them is a clinical decision based on your specific pain pattern, not an insurance limitation.
Talk to a pain specialist about which neuromodulation option fits
The right choice between SCS and DRG comes from a careful evaluation of your pain pattern, prior treatments, and goals. Schedule a consultation or call our office at (847) 981-3630.